Paracetamol/ Caffeine/ Ephedrine/ Chlorphenamine
Indications
Registered South African indications:
- Symptomatic relief of colds and influenza
Contraindications (ZA)
Registered South African contraindications
- Hypersensitivity to the active ingredient or to any of the excipients in this combination product
- Severe liver function impairment
- Severe kidney function impairment
- Cardiovascular disease
- Kidney disease
- Hypertension
- Hyperthyroidism
- Hyperexcitability
- Phaeochromocytoma
- Closed-angle glaucoma
- Prostatism
- Bladder dysfunction
- Patients being treated with monoamine oxidase inhibitors or within 14 days of stopping such treatment
- Epilepsy and all convulsive states
- During an attack of asthma
Warnings & precautions
South African recommendations
- Pregnancy
- Breastfeeding
- Mild to moderate renal impairment
- Mild to moderate hepatic impairment
Elderly
- Elderly patients are most susceptible to the antimuscarinic effects of chlorpheniramine; sedation and hypotension
Excess doses
- Dosages in excess of those recommended may cause liver damage. Patient should not use continuously for more than 10 days without consulting a doctor
- If no relief is obtained with the recommended dosage, advise patient to consult a doctor
Drowsiness and impaired concentration
- This combination medicine may lead to drowsiness and impaired concentration, which may be aggravated by the simultaneous intake of alcohol or other central nervous system depressant agents
May affect the ability to drive and use machines
- Patients should be warned not to drive a motor vehicle, operate dangerous machinery or climb dangerous heights, as impaired decision making could lead to accidents
Caffeine
- Caution to patients with a history of peptic ulceration or hyperacidity
Caffeine intake
- Prolonged high intake of caffeine may lead to tolerance to some of the pharmacological actions and physical signs of withdrawal if intake is discontinued abruptly
Ephedrine
Caution to patients with:
- Organic heart disease
- Cardiac decompensation
- Angina of effort
Anaesthesia use
- Avoid during anaesthesia with cyclopropane, halothane or other halogenated anaesthetics
Patients with angina pectoris
- Anginal pain may be precipitated in patients with angina pectoris
Adult dosage (ZA)
Forms avail. in SA and covered in this monograph: tab
South African registered indications and dosages
Symptomatic relief of colds and influenza
- Nasal congestion, and minor aches and pains
Paracetamol/ Caffeine/ Ephedrine/ Chlorphenamine
200/20/6/2 (mg)
- Oral (tab): 2 tab, 4hrly
Paediatric dosage (ZA)
Paed. forms avail. in SA and covered in this monograph: tab
South African registered indications and dosages
Symptomatic relief of colds and influenza
- Nasal congestion, and minor aches and pains
Paracetamol/ Caffeine/ Ephedrine/ Chlorphenamine
200/20/6/2 (mg)
- Younger than 8 years: Not recommended
- Between 8-12 years: 1 tab, 4hrly
- Older than 12 years: See adult dosage
Pregnancy & lactation
Pregnancy
South African recommendations
- Caution
- Safety in pregnancy has not been established
Breastfeeding
South African recommendations
- Caution
- Safety in lactation has not been established
Fertility
South African recommendations
- No information available
Renal impairment
South African recommendations
- Mild to moderate: Caution; no dose adjustment recommended
- Severe: Contraindicated
- Kidney disease: Contraindicated
Hepatic impairment
South African recommendations
- Mild to moderate: Caution; no dose adjustment recommended
- Severe: Contraindicated
Elderly
South African recommendations
- Caution; no dose adjustment recommended
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
Endocrine and Metabolic Disorders
- Pancreatitis
Skin and Subcutaneous Tissue Disorders
- Skin rashes
Immune, Blood and Lymphatic System Disorders
- Haematological reactions
- Thrombocytopenia
- Leucopenia
- Pancytopenia
- Neutropenia
- Agranulocytosis
- Allergic reactions
Caffeine
- Adverse effects of caffeine commonly affect the gastrointestinal tract and central nervous system
Ephedrine
Central Nervous System Disorders
- Fear
- Anxiety
- Restlessness
- Insomnia
- Tremor
- Confusion
- Irritability
- Psychotic states
- Headache (common)
Respiratory Disorders
- Dyspnoea
Gastrointestinal Disorders
- Reduced appetite
- Nausea and vomiting
Genitourinary Disorders
- Difficulty in micturition
- Urinary retention
Endocrine and Metabolic Disorders
- Altered metabolism including disturbances of glucose metabolism, sweating, and hypersalivation
Others
- Weakness
Chlorphenamine
Central Nervous System Disorders
- Sedation, varying from slight drowsiness to deep sleep
- Inability to concentrate
- Lassitude
- Inco-ordination
- Paradoxical CNS stimulation may occur especially in children
- Insomnia
- Nervousness
- Euphoria
- Irritability
- Tremors
- Nightmares (rarely)
- Hallucinations
- Convulsions
- Extrapyramidal symptoms
- CNS stimulation (high doses)
Cardiovascular Disorders
- Transient bradycardia followed by tachycardia with palpitations and arrhythmias (high doses)
Respiratory Disorders
- Thickened respiratory secretions
- Tightness of the chest
Gastrointestinal Disorders
- Reduction in tone and motility of the gastrointestinal tract resulting in constipation and increased gastric reflux
- Dry mouth
- Nausea and vomiting
- Diarrhoea
- Epigastric pain
Genitourinary Disorders
- Urinary difficulty and retention
Sensory Disorders
- Blurred vision
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol/ Caffeine/ Ephedrine/ Chlorphenamine
- Cardiac glycosides
- Quinidine
- Tricyclic antidepressants
Ephedrine
- Cyclopropane
- Halothane or other halogenated anaesthetics
Chlorphenamine
- Central nervous system depressants
- Alcohol
- Barbiturates
- Hypnotics
- Opioid analgesics
- Anxiolytic sedatives
- Neuroleptics
- Monoamine oxidase inhibitors
- Antimuscarinic medicines
- Atropine
- Tricyclic antidepressants
Monitoring
None routine. Specific cases may require
- Hepatic function
- Renal function
Mechanism of action
Paracetamol/ caffeine/ ephedrine/ chlorphenamine has analgesic, antipyretic, sympathomimetic and antihistaminic properties.
Dosage forms
- Tablet
Formulation
COMBINATION PREPARATIONS
Paracetamol/ Caffeine/ Ephedrine/ Chlorpheniramine
Tablet 200mg/20mg/6mg/2mg
- Colcleer (Adcock)
- Flusin (Pharmacare)
- Sinucon (Ascendis)
- Sinuend (Alliance Pharma) originator
References
1. PI - SINUEND (tablets), Ascendis Pharma (Pty) Ltd - Ascendis Pharma (Pty) Ltd Date of the most recently revised package insert as approved by Council 02 February 2015 - Doc version March 2021 Downloaded online 07 Nov 2023 [https://medsinfoportal.sahpra.org.za/pi/ebab29b4aa8b6cdabba124beeaef4a62.pdf] 2. NAPOS The Drug Database for Acute Porphyria: Paracetamol, combinations excl. psycholeptics N02BE51 - Downloaded online 06 Nov 2023 [https://www.drugs-porphyria.org/mono.php?id=3563] 3. South African Institute for Drug-Free Sport; Sinuend; Accessed online 08 November 2023 [http://www.drugfreesport.org.za/online-medication-check/] **No SPC available
Brands & products
5 products · cached snapshot- Chlorpheniramine maleate (syn. Chlorphenamine)Colcleer
- Flusin
- Sinucon
- Sinuend
TABTablet· 5 products
from R21.74| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Sinuend | 200 mg;mg;mg;mg | 20 | Alliance Pharma (Pty) Ltd | R21.74 |
| Colcleer | 200 mg;mg;mg;mg | 120 | Adcock Ingram Limited | R31.46 |
| Sinucon | 200 mg;mg;mg;mg | 20 | Akacia Health Care (Pty) Ltd | R36.15 |
| Flusin | 200 mg;mg;mg;mg | 24 | Pharmacare Limited, Woodmead | R59.03 |
| Colcleer | 200 mg;mg;mg;mg | 1000 | Adcock Ingram Limited | R262.18 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.